Use of IGF-II/IGF-IIE binding for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis

Details for Australian Patent Application No. 2009303453 (hide)

Owner Dyax Corp.

Inventors Cohen, Edward H.

Agent Cullens

Pub. Number AU-A-2009303453

PCT Pub. Number WO2010/045315

Priority 61/105,229 14.10.08 US

Filing date 14 October 2009

Wipo publication date 22 April 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/045315 Priority application(s): WO2010/045315

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009303460-Process for extracting cardiac glycodides and compositions

2009303451-System and method for voice activation of surgical instruments